These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26237326)

  • 21. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results.
    Stitzer ML; Peirce J; Petry NM; Kirby K; Roll J; Krasnansky J; Cohen A; Blaine J; Vandrey R; Kolodner K; Li R
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):344-50. PubMed ID: 17696681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of prize-based contingency management in methadone maintenance treatment programs.
    Sindelar JL; Olmstead TA; Peirce JM
    Addiction; 2007 Sep; 102(9):1463-71. PubMed ID: 17645428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The brief abstinence test: voucher-based reinforcement of cocaine abstinence.
    Robles E; Silverman K; Preston KL; Cone EJ; Katz E; Bigelow GE; Stitzer ML
    Drug Alcohol Depend; 2000 Feb; 58(1-2):205-12. PubMed ID: 10669073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent alcohol dependence among methadone-maintained cocaine abusers is associated with greater abstinence.
    Byrne SA; Petry NM
    Exp Clin Psychopharmacol; 2011 Apr; 19(2):116-22. PubMed ID: 21463068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prize reinforcement contingency management for cocaine dependence: integration with group therapy in a methadone clinic.
    Petry NM; Martin B; Simcic F
    J Consult Clin Psychol; 2005 Apr; 73(2):354-9. PubMed ID: 15796645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives.
    Vandrey R; Bigelow GE; Stitzer ML
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):338-43. PubMed ID: 17696680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-cost contingency management for treating cocaine- and opioid-abusing methadone patients.
    Petry NM; Martin B
    J Consult Clin Psychol; 2002 Apr; 70(2):398-405. PubMed ID: 11952198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broad beneficial effects of cocaine abstinence reinforcement among methadone patients.
    Silverman K; Wong CJ; Umbricht-Schneiter A; Montoya ID; Schuster CR; Preston KL
    J Consult Clin Psychol; 1998 Oct; 66(5):811-24. PubMed ID: 9803700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.
    Epstein DH; Hawkins WE; Covi L; Umbricht A; Preston KL
    Psychol Addict Behav; 2003 Mar; 17(1):73-82. PubMed ID: 12665084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials.
    Panlilio LV; Stull SW; Bertz JW; Burgess-Hull AJ; Kowalczyk WJ; Phillips KA; Epstein DH; Preston KL
    Psychopharmacology (Berl); 2020 Nov; 237(11):3369-3381. PubMed ID: 32990768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients.
    Tzilos GK; Rhodes GL; Ledgerwood DM; Greenwald MK
    Exp Clin Psychopharmacol; 2009 Oct; 17(5):320-5. PubMed ID: 19803631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial abstinence status and contingency management treatment outcomes: does race matter?
    Montgomery L; Carroll KM; Petry NM
    J Consult Clin Psychol; 2015 Jun; 83(3):473-81. PubMed ID: 25798729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The brief abstinence test: effects of continued incentive availability on cocaine abstinence.
    Katz EC; Robles-Sotelo E; Correia CJ; Silverman K; Stitzer ML; Bigelow G
    Exp Clin Psychopharmacol; 2002 Feb; 10(1):10-7. PubMed ID: 11866247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contingency management is efficacious and improves outcomes in cocaine patients with pretreatment marijuana use.
    Alessi SM; Rash C; Petry NM
    Drug Alcohol Depend; 2011 Oct; 118(1):62-7. PubMed ID: 21440999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shaping cocaine abstinence by successive approximation.
    Preston KL; Umbricht A; Wong CJ; Epstein DH
    J Consult Clin Psychol; 2001 Aug; 69(4):643-54. PubMed ID: 11550730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs.
    Silverman K; Robles E; Mudric T; Bigelow GE; Stitzer ML
    J Consult Clin Psychol; 2004 Oct; 72(5):839-54. PubMed ID: 15482042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol use disorders are associated with increased HIV risk behaviors in cocaine-dependent methadone patients.
    Meredith SE; Rash CJ; Petry NM
    J Subst Abuse Treat; 2017 Dec; 83():10-14. PubMed ID: 29129191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of methadone take-home contingencies with persistent opiate and cocaine abusers.
    Chutuape MA; Silverman K; Stitzer ML
    J Subst Abuse Treat; 1999 Jan; 16(1):23-30. PubMed ID: 9888118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.